267
Views
15
CrossRef citations to date
0
Altmetric
Research Article

Development of a novel polyethylene glycol-corticosteroid-conjugate with an acid-cleavable linker

, &
Pages 434-445 | Received 18 Mar 2010, Accepted 11 Jun 2010, Published online: 02 Aug 2010

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Articles from other publishers (14)

Mujeeb Ur-Rehman, Franceline Reynaud, Sinda Lepetre, Sonia Abreu, Pierre Chaminade, Elias Fattal & Nicolas Tsapis. (2023) Modulation of release and pharmacokinetics from nanoscale lipid prodrugs of dexamethasone with variable linkage chemistry. Journal of Controlled Release 360, pages 293-303.
Crossref
Barbara Tessier, Nicolas Tsapis, Elias Fattal & Laurence Moine. (2023) Emerging nanoparticle platforms to improve the administration of glucocorticoids. Journal of Controlled Release 358, pages 273-292.
Crossref
Hong Guo, Jibin Guan, Xian Wu, Yushuang Wei, Jiaqi Zhao, Yan Zhou, Faqian Li & Hong-Bo Pang. (2023) Peptide-guided delivery improves the therapeutic efficacy and safety of glucocorticoid drugs for treating acute lung injury. Molecular Therapy 31:3, pages 875-889.
Crossref
Shuai Jiang, Domenik Prozeller, Jorge Pereira, Johanna Simon, Shen Han, Sebastian Wirsching, Michael Fichter, Milagro Mottola, Ingo Lieberwirth, Svenja Morsbach, Volker Mailänder, Stephan Gehring, Daniel Crespy & Katharina Landfester. (2020) Controlling protein interactions in blood for effective liver immunosuppressive therapy by silica nanocapsules. Nanoscale 12:4, pages 2626-2637.
Crossref
Cody P. Coyne & Lakshmi Narayanan. (2019) Carnosic Acid, Tangeretin, and Ginkgolide-B Anti-neoplastic Cytotoxicity in Dual Combination with Dexamethasone-[anti-EGFR] in Pulmonary Adenocarcinoma (A549). Anti-Cancer Agents in Medicinal Chemistry 19:6, pages 802-819.
Crossref
Cody P. Coyne & Lakshmi Narayanan. (2018) Anti-neoplastic cytotoxicity by complementary simultaneous selective “targeted” delivery for pulmonary adenocarcinoma: fludarabine-(5′-phosphoramidate)-[anti-IGF-1R] in dual-combination with dexamethasone-(C21-phosphoramidate)-[anti-EGFR]. Journal of Pharmaceutical Investigation 49:1, pages 173-193.
Crossref
Thanapha Numpilai, Thongthai Witoon, Metta Chareonpanich & Jumras Limtrakul. (2017) Impact of physicochemical properties of porous silica materials conjugated with dexamethasone via pH-responsive hydrazone bond on drug loading and release behavior. Applied Surface Science 396, pages 504-514.
Crossref
Ilknur Yildirim, Sarah Crotty, Claas H. Loh, Grit Festag, Christine Weber, Pier-Francesco Caponi, Michael Gottschaldt, Matthias Westerhausen & Ulrich S. Schubert. (2016) End-functionalized polylactides using a calcium-based precatalyst: Synthesis and insights by mass spectrometry. Journal of Polymer Science Part A: Polymer Chemistry 54:3, pages 437-448.
Crossref
Richard d'Arcy & Nicola Tirelli. (2014) Fishing for fire: strategies for biological targeting and criteria for material design in anti-inflammatory therapies. Polymers for Advanced Technologies 25:5, pages 478-498.
Crossref
Rajesh A. Shenoi, Fang Gao, Muhammad Imran Ul-Haq & Jayachandran N. Kizhakkedathu. 2014. Chemistry of Bioconjugates. Chemistry of Bioconjugates 77 103 .
Wenyu Li, Peng Zhang, Kun Zheng, Qiaoling Hu & Youxiang Wang. (2013) Redox-triggered intracellular dePEGylation based on diselenide-linked polycations for DNA delivery. Journal of Materials Chemistry B 1:46, pages 6418.
Crossref
Fumiyoshi Yamashita & Mitsuru Hashida. (2013) Pharmacokinetic considerations for targeted drug delivery. Advanced Drug Delivery Reviews 65:1, pages 139-147.
Crossref
Fang Yuan, Ling-dong Quan, Liao Cui, Steven R. Goldring & Dong Wang. (2012) Development of macromolecular prodrug for rheumatoid arthritis. Advanced Drug Delivery Reviews 64:12, pages 1205-1219.
Crossref
Bart J. Crielaard, Twan Lammers, Raymond M. Schiffelers & Gert Storm. (2012) Drug targeting systems for inflammatory disease: One for all, all for one. Journal of Controlled Release 161:2, pages 225-234.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.